JobRx.com

Boston Scientific warned you. It slashed earnings guidance after cyberattack hits business. Boston Scientific warned this would be the case but Wall Street was still reacting negatively on Wednesday after the company slashed full-year guidance. buff.ly/uK03vUt

Lilly's retatrutide outshines Ozempic on weight loss, blood sugar control in trial Eli Lilly said on Wednesday its experimental next-generation obesity drug, retatrutide, outperformed Novo Nordisk's Ozempic on blood sugar control and delivered more ... buff.ly/T7rYmC2

Pharmacy Technician- FULL TIME, Westerville, Ohio - OH Meijer As a family company, we serve people and communities. When you work at Meijer, you're provided with career and community opportunities centered around leadership, personal growth ... buff.ly/83RvpIk

Medical Science Liaison, Team Lead - Rare Emergency Medicine, BTG PLC Advanced, doctorate-level degree in scientific discipline (i.e., MD, PharmD, PhD). Experience in leading and managing MSL Team. A minimum of five years of experience in medical ... buff.ly/mhtQErI

Nestlé's CEO says he drinks at least 8 cups of coffee daily and tackles his biggest tasks in the a.m. Nestlé's CEO drinks "at least" eight cups of coffee daily — and downs the first five by 10 a.m. Philipp Navratil enjoys his coffee black and cold ... buff.ly/alpUAv0

Eli Lilly merging US, international units to form Lilly Global Markets in 2027 Effective Jan. 1, 2027, Eli Lilly (LLY) will combine its US and international businesses to become Lilly Global Markets. "Bringing these organizations together will ... buff.ly/sous3HF

Dollar General sued by FTC and 20 states over alleged deceptive pricing practices The complaint alleges that Dollar General has, for years, repeatedly mislabeled prices, overcharged consumers and failed to correct the issue. buff.ly/mu7FWQB

Retail Pharmacist (Full-time, Multiple openings!), ShopRite, Sparta, New Jersey - NJ buff.ly/yfAY6pr

Moderna falls as William Blair is latest to downgrade on valuation Moderna (MRNA) shares extended a recent downtrend on Tuesday after William Blair became the latest brokerage to downgrade the biotech, citing valuation concerns following a late- ... buff.ly/RmeJTDe

HCA Healthcare profit slips but revenue rises HCA Healthcare reported a lower profit in the third quarter after a surge in uninsured patients offset higher revenue, but said it expects full-year results at the high end of its guidance. buff.ly/Ukm9ePl

Reckitt shares drop after Lysol shortage prompts guidance trim Shares in Reckitt Benckiser slid after the consumer-goods giant lowered its full-year outlook, hit by Lysol manufacturing disruption that dragged on sales in North America. buff.ly/rzD7GSu

Novartis raises core profit guidance, books $1.9 billion hit from drug trial setback Novartis raised its full-year core operating income guidance on Tuesday but also booked a $1.9 billion partial impairment charge related to a pipeline setback in ... buff.ly/SjV1JHH

Medicus Pharma restores Nasdaq compliance; stock rises premarket Medicus Pharma (MDCX) announced Monday that it regained compliance with Nasdaq’s $1 minimum bid price requirement. Nasdaq confirmed compliance after the stock’s closing bid price ... buff.ly/PxEJF2p

Obesity drug developer Corxel to go public in US via SPAC deal Obesity drug developer Corxel Pharmaceuticals will go public in the US through a merger with special purpose acquisition company Amanat Acquisition Corp, the companies announced on Monday. buff.ly/pZeCVqi

Moderna’s cancer vaccine rally hits a wall. This other drugmaker stole the show. Moderna and Merck were primed for a victory lap at Europe’s premier oncology conference, but it was another drugmaker that stole the show. buff.ly/Yftf3M6

Pharmacy Leaders across Kentucky & Tennessee, PeopleSuite Talent Solutions Our client is seeking an experienced Pharmacy Leader across Kentucky, and Tennessee to oversee all aspects of pharmacy operations, deliver exceptional patient care, and lead ... buff.ly/9Kb9zrK

Health care roundup: Market talk The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. buff.ly/Y7gzGCm

Bon Secours nears $6B takeover of Surgery Partners, FT reports Bon Secours Mercy Health is nearing an agreement to acquire a controlling stake in Surgery Partners (SGRY) in a transaction valuing the outpatient surgical care provider at approximately ... buff.ly/svcshG7

China approves Bayer blood thinner asundexian China's drug regulator said on Monday it approved the blood thinner asundexian from Bayer, a potential boost for the German drugmaker in the world's second-largest pharmaceutical market as it moves to ... buff.ly/xBFQLtx

Mankind Pharma's quarterly profit jumps 39% on strong chronic drug demand Indian drugmaker Mankind Pharma reported an over 39% jump in second-quarter profit on Monday, helped by strong demand for chronic therapies such as diabetes and cardiac ... buff.ly/eW48HH1